Reproductive Health
Active Resources: 6
-
Presentation slides from the Mountain West AETC's CROI 2020 review (3/26/20) on antiretroviral therapy (ART) safety & side effects.
Type: Training MaterialsPublish Date: 4/7/2020 -
These resources were developed under the Improving Sexually Transmitted Infection Screening and Treatment among People with or at Risk
Type: Clinical Reference ToolsPublish Date: 1/20/2020 -
Excerpt from Introduction: The Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, a working group of t
Type: GuidelinesPublish Date: 12/24/2019Review Date: 12/30/2020 -
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.
Type: Online and Self-Paced LearningPublish Date: 12/4/2019 -
Quick guide to oral contraceptives and HIV medications drug interactions.
Type: Clinical Reference ToolsPublish Date: 5/3/2017Review Date: 5/3/2017 -
Main website includes related resources, updates, and formats for print and mobile devices.
Topics covered include:
Type: GuidelinesPublish Date: 6/5/2015
Archive Resources: 9
-
Infographic developed by TheBody.com dispels 7 myths about HIV and pregnancy. Download a high quality image for your clinic or for training.
Type: Clinical Reference ToolsPublish Date: 3/10/2017Review Date: 5/5/2021 -
This guide sets forth best practices for sexual and reproductive health.
Type: Articles, Reports, and ManualsPublish Date: 6/1/2016Review Date: 4/23/2021 -
Development of a Safer Conception Counseling Toolkit in Kenya: Stigma, Fears, and Recommendations for the Delivery of Services.
Type: Clinical Reference ToolsPublish Date: 2/22/2016Review Date: 4/23/2021 -
Infographic provides recommendations to address gaps in the HIV care continuum related to HIV treatment and prevention for women and their partners.
Type: Clinical Reference ToolsPublish Date: 9/4/2015 -
This Policy Brief is a follow-up document to the 2011 WHO document, "Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender pe
Type: Articles, Reports, and ManualsPublish Date: 8/27/2015 -
This video examines the epidemiology and the risk assessment for acquiring sexually transmitted infections, including HIV infection among older adults.
Type: Online and Self-Paced LearningPublish Date: 4/1/2015Review Date: 5/8/2019 -
This video will provide basic principles to consider when taking a sexual history on an older adult.
Type: Online and Self-Paced LearningPublish Date: 4/1/2015Review Date: 5/8/2019 -
This guideline is a comprehensive compilation of federal recommendations about biomedical, behavioral, and structural interventions that can help reduce the risk of HIV transmission from persons wi
Type: GuidelinesPublish Date: 12/11/2014 -
This toolkit was designed specifically for use by health centers, and offers a variety of resources, including recommended screening questions and subsequent risk assessments; an algorithm; sample
Type: Clinical Reference ToolsPublish Date: 8/1/2014Review Date: 11/30/2015
Articles: 3
-
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Two pharmacokinetic studies from AIDS 2018 help elucidate the disposition of tenofovir alafenamide (TAF) and cobicistat-boosted darunavir during pregnancy.
The IMPAACT P1026s study examined plasma concentrations of TAF with and without cobicistat in 43 pregnant women. For women taking...
-
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Although DTG currently is not a desirable medication for women to take pre-conception (see Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects), findings from the DolPHIN study suggest that it may be a very useful agent for women who start ART during late pregnancy....
-
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...